Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 29 May 2024 | 2 May 2024 |
3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter / year ended March 31 2024. Submission of Audited Financial Results for the Quarter and Financial Year ended 31st March,2024. (As Per BSE Announcement Dated on:29/05/2024) | ||
Board Meeting | 9 Feb 2024 | 17 Jan 2024 |
3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December 2023. Outcome Of The Board Meeting- Unaudited Financial Results For The Quarter And Nine Months Ended 31st December, 2023. (As Per BSE Announcement dated on 09.02.2024) | ||
Board Meeting | 10 Nov 2023 | 31 Oct 2023 |
KILPEST INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30th September 2023. Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September, 2023 (As Per BSE Announcement Dated on 10.11.2023) Newspaper Publication (As Per BSE Announcement dated on 11.11.2023) | ||
Board Meeting | 10 Oct 2023 | 28 Sep 2023 |
Allotment of Shares pursuant to Scheme of Amalgamation Outcome of Board Meeting (As Per BSE Announcement Dated on 10/10/2023) | ||
Board Meeting | 11 Sep 2023 | 11 Sep 2023 |
Outcome of Board Meeting under Regulation 30 SEBI (LODR), 2015 | ||
Board Meeting | 29 Aug 2023 | 21 Aug 2023 |
KILPEST INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2023 inter alia to consider and approve the Record Date for the purpose of determining the shareholders of 3B BlackBio Biotech India Limited (Transferor Company) to whom equity shares of the Company would be allotted pursuant to the Scheme of Amalgamation. | ||
Board Meeting | 11 Aug 2023 | 2 Aug 2023 |
KILPEST INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve the Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2023 Standalone and Consolidated Un-Audited Financial Result for the quarter ended on 30th June,2023 Outcome of Board Meeting (As Per BSE Announcement Dated on 11.08.2023) |
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.